论文部分内容阅读
对１８例晚期大肠癌患者进行ＴＩＬ免疫治疗。研究结果表明：ＴＩＬ治疗晚期大肠癌，可使患者腹水明显减少或消失，瘤体部分缩小，存活期延长，体重增加，疼痛减轻。经ＣＤ４／ＣＤ８比值，ＳＩＬ２Ｒ、ＮＫＣ、ＢＣＧ免疫功能检测，证明ＴＩＬ治疗晚期大肠癌患者可调节机体免疫平衡，促进机体免疫功能提高，增强机体的抗癌消瘤能力，达到减轻痛苦，延长寿命的作用。本文认为：在晚期大肠癌的综合治疗中，ＴＩＬ免疫疗法可作为重要方法之一。
TIL immunotherapy was performed on 18 patients with advanced colorectal cancer. The results of the study show that: TIL treatment of advanced colorectal cancer, patients can significantly reduce the ascites or disappeared, shrinking the tumor part, extended survival, weight gain, pain relief. The CD4/CD8 ratio, immune function test of SIL2R, NKC, and BCG proved that TIL can regulate immune balance in patients with advanced colorectal cancer, promote immune function, enhance the body’s anti-cancer anti-tumor ability, relieve pain and prolong lifespan. effect. This article believes that TIL immunotherapy may be one of the important methods in the comprehensive treatment of advanced colorectal cancer.